DOROTHY AGBAFE-MOSLEY: Open Payments
NPI 1881898187 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,146 in 45 payments from 17 companies in 2025. Trend: 2023 $985 · 2024 $1,918 · 2025 $1,146
Food & beverage: $1,146
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $301 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $286 |
| Exact Sciences Corporation | 6 | $121 |
| Paratek Pharmaceuticals, Inc. | 3 | $57 |
| Braeburn Inc. | 3 | $53 |
| ABBVIE INC. | 2 | $43 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Actelion Pharmaceuticals US, Inc. | 2 | $36 |
| Vanda Pharmaceuticals Inc. | 1 | $32 |
| Gilead Sciences, Inc. | 1 | $30 |
Products named: CAPLYTA, BREZTRI, Cologuard Collection Kit, FARXIGA, NUZYRA, BRIXADI, TRELEGY ELLIPTA, OPSUMIT.
Industry payments across NC — which companies pay providers there.
